Published financial brief
5141B
TRANSUNION INTRMED HLDGS INC
- As of
- 2013-12-31
- Source
- Supabase fundamentals
- Calculator
- financial-roic-1.0.0
- Published
- 7/26/2026
3 data notes
- Only 4 of 5 periods.
- Input provenance requires review.
- One or more values are unavailable.
Exact-period record
Fundamentals
4 reported periods
| Metric | FY 20102010-12-31 | FY 20112011-12-31 | FY 20122012-12-31 | FY 20132013-12-31 |
|---|---|---|---|---|
| Financial statements | ||||
| RevenueUSD millions | 956.5 | 1,024 | 1,140 | 1,183.2 |
| Cost of goods soldUSD millions | 395.8 | 421.5 | 470.2 | 472.4 |
| Selling, general and administrative expenseUSD millions | 263 | 264.5 | 383.7 | 349.7 |
| Depreciation and amortizationUSD millions | 81.6 | 85.3 | 144.2 | 186.8 |
| Net incomeUSD millions | 28.4 | 41.3 | -11.9 | 43.2 |
| Operating profit (EBIT)USD millions | 216.1 | 252.7 | 141.9 | 174.3 |
| Income taxesUSD millions | 46.3 | 17.8 | 12.8 | 21.8 |
| Short-term debtUSD millions | 15.1 | 21.8 | 10.6 | 13.8 |
| Long-term debtUSD millions | 1,590.9 | 1,579.4 | 1,672.3 | 1,854.8 |
| Cash and equivalentsUSD millions | 131.2 | 107.8 | 154.3 | 111.2 |
| ReceivablesUSD millions | 143.6 | 141.3 | 167.4 | 170.7 |
| InventoryUSD millions | 0 | 0 | 0 | 0 |
| PayablesUSD millions | 65.8 | 75.1 | 77.5 | 100.2 |
| Net property, plant and equipmentUSD millions | 186.1 | 202.4 | 121.2 | 150.4 |
| Capital expenditureUSD millions | 46.8 | 74 | 69.2 | 81.7 |
| Operating cash flowUSD millions | 200.4 | 203.2 | 144.1 | 239.1 |
| Prepaid expensesUSD millions | 25.1 | 37.1 | 33.8 | 34.9 |
| AccrualsUSD millions | 73.5 | 74.4 | 84.1 | 92 |
| EBITDAUSD millions | 297.7 | 338 | 286.1 | 361.1 |
| Working capitalUSD millions | 128.1 | 105.2 | 181.5 | 75.5 |
| Working capital requirementUSD millions | 77.8 | 66.2 | 89.9 | 70.5 |
| Total debtUSD millions | 1,606 | 1,601.2 | 1,682.9 | 1,868.6 |
| Free cash flowUSD millions | 153.6 | 129.2 | 74.9 | 157.4 |
| Unlevered free cash flowUSD millions | 130.4 | 208.6 | 51.3 | 246 |
| Returns and ratios | ||||
| ROICratio | 11.5% | 19.4% | 0% | 2% |
| Pre-tax ROICratio | 26.1% | 26.4% | 2.5% | 2.9% |
| Effective tax rateratio | 55.8% | 26.5% | 100% | 30.3% |
| Revenue growthratio | —missing | 7.1% | 11.3% | 3.8% |
| EBIT / Revenueratio | 22.6% | 24.7% | 12.4% | 14.7% |
| Revenue / Invested capitalmultiple | 1.15× | 1.07× | 0.2× | 0.2× |
| Cogs Over Revenuesratio | 41.4% | 41.2% | 41.2% | 39.9% |
| Sga Over Revenuesratio | 27.5% | 25.8% | 33.7% | 29.6% |
| Da Over Revenuesratio | 8.5% | 8.3% | 12.6% | 15.8% |
| Nfa Over Revenuesratio | 19.5% | 19.8% | 10.6% | 12.7% |
| Wcr Over Revenuesratio | 8.1% | 6.5% | 7.9% | 6% |
| Debt Over Ebitdamultiple | 5.39× | 4.74× | 5.88× | 5.17× |
| St Debt Over Cashmultiple | 0.12× | 0.2× | 0.07× | 0.12× |
| Interest Over Ebitdamultiple | 0.37× | 0.38× | 0.41× | 0.29× |
| Interest Over Nocf Nicfmultiple | 0.72× | 0.99× | 1.57× | 0.67× |
| Nsf Over Wcrmultiple | -1.49× | -1.3× | -1.6× | -1.38× |
Ask this snapshot
Research assistant
5141B · annualSnapshot be139531
Answers use only this published snapshot. The assistant will say when the data is insufficient and does not create forecasts, scenarios, or investment advice.
0 / 2,000